Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma

Application of dendritic cells (DCs) pulsed with tumor-associated antigens is considered attractive in immunotherapy for hepatocellular carcinoma (HCC). In order to efficiently prime tumor-associated antigens specific for cytotoxic T lymphocytes (CTLs), it is important that DCs present tumor-associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Huiting, Li, Bing, Zheng, Lan, Wang, Haixia, Zhang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217026/
https://www.ncbi.nlm.nih.gov/pubmed/27351282
http://dx.doi.org/10.18632/oncotarget.10269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217026/
https://www.ncbi.nlm.nih.gov/pubmed/27351282
http://dx.doi.org/10.18632/oncotarget.10269

Ejemplares similares